References FASEB Journal Biological activities of thymosin 4 defined by active peptide sequences (TB500 fragment identification) Journal of Chromatography A (PubMed) Doping control analysis of TB500 as synthetic thymosin 4 fragment in biological samples WADA Scientific Research Investigation of TB500 metabolism, synthesis of metabolites, and detection limits Racing Medication & Testing Consortium Thymosin 4 regulatory bulletin (TB500 use in equine sports medicine) Journal of Investigative Dermatology (PubMed) Thymosin beta4 accelerates wound healing (preclinical wound healing model) FASEB Journal (PubMed) Active site mapping of thymosin 4 fragments for angiogenesis and cell migration Verified Peptides Storage Guide Lyophilized peptide storage best practices (temperature, humidity, light protection) Empower Pharmacy Bacteriostatic water injection guidelines (0.9% benzyl alcohol, multidose vial stability) NCBI Bookshelf Best practices for subcutaneous injection (aseptic technique, site rotation) WADA Prohibited List TB500 classification as prohibited substance in competitive sports Journal of Investigative Dermatology Thymosin 4 wound healing mechanisms (collagen deposition, angiogenesis, granulation tissue) Journal of Chromatography B (PubMed) Quantification of TB500 metabolites and wound healing activity screening (prodrug hypothesis) Legion Peptides TB500 (5 mg & 10 mg) product page (purity specifications and batch documentation) Research Resources CJC-1295 DAC (2 mg & 5 mg Vial) Dosage Protocol Quickstart Highlights CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH)
Brightens skin, fades dark spots, and provides deep cleansing for a radiant complexion
Manufacturers determine these dates through extensive stability testing, often spanning years, that proves the medication maintains at least 90% potency through the labeled date
Change the concentration to 10mg/ml and the volume drops to 0.05ml for the identical 0.5mg dose
Antibodies and reagents The anti--actin (cat#3700), anti--tubulin (cat#3873), anti-SLC7A11 (cat#12691), anti-ER (cat#13258), phospho-Tyr-100 (cat#9411), and phospho-ERK (Thr202/Tyr204) (cat#4370) were purchased from Cell Signaling Technology (Danvers, MA, USA)
